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METHOD

A PCR-based platform for microRNA expression
profiling studies
XIAOWEI WANG
Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri 63108, USA

ABSTRACT
MicroRNAs (miRNAs) are newly identified small noncoding RNA molecules that play important regulatory roles in many
biological processes. Changes in miRNA expression are associated with a variety of normal physiological processes as well as
with human diseases including cancer. Thus, one important way to characterize miRNA function is to identify changes in
miRNA expression profiles. To date, microarrays are the most widely used technique for miRNA expression profiling analysis.
However, there are major limitations when microarrays are applied to miRNA profiling studies. Here we report a new PCRbased assay platform for miRNA expression profiling analysis. The primers associated with these miRNA assays were designed
using a novel bioinformatics algorithm that has incorporated many primer selection features for improved assay specificity,
sensitivity, and homogeneity. The primer design algorithm has been extensively validated experimentally and has been shown to
have robust performance for the measurement of miRNA expression in a variety of biological samples at a low cost.
Keywords: microRNA; real-time PCR; expression profiling

INTRODUCTION
MicroRNAs (miRNAs) are noncoding RNAs that regulate
many important biological processes (Ambros 2004; Miska
2005). Over 600 human miRNAs have been identified in
recent years using both computational and experimental
approaches (Griffiths-Jones et al. 2006). A typical mature
miRNA molecule is only z22-nucleotides (nt) long, which
is much shorter than the length of most other gene
sequences in humans. Despite the short sequence length
and the relatively small number of miRNAs, recent studies
have shown that thousands of human protein-coding genes
are regulated by miRNAs (Lewis et al. 2005; Lim et al. 2005;
Wang and Wang 2006). Thus, deregulated expression of
miRNAs may have a profound effect on miRNA-mediated
biological pathways.
One major challenge in miRNA research is to accurately
and conveniently determine the expression level of miRNAs
in various experimental systems. As deregulated expression
of miRNAs often indicates functional deregulation, screening for miRNAs with altered expression profiles is likely to
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provide clues for the involvements of miRNAs in disease
development. In particular, miRNA expression has been
extensively studied in human cancers, and altered miRNA
expression signatures have been demonstrated to be promising cancer biomarkers (Jay et al. 2007; Yu et al. 2007). At
present, this is a field under intense study, and many
studies have been published in recent years on using
miRNA expression profiles for cancer diagnosis and prognosis. To date, most miRNA expression profiling studies
had relied on miRNA microarrays (Yin et al. 2008). Despite
their wide use for miRNA profiling, there are some major
limitations associated with miRNA microarrays. For example, a large amount of high-quality RNA samples are
usually required for the microarray experiments, which is
often a major challenge for miRNA expression analysis of
clinical samples. In addition, microarray detection specificity is still a major issue because miRNA molecules are
very short and many miRNAs differ by only one or a few
bases. Another practical consideration is the high cost of
microarrays, which discourages the extensive use of microarrays to profile miRNA expression in many biological
samples.
Given the relatively small number of miRNAs in
humans, it is possible to perform real-time polymerase
chain reaction (PCR) in lieu of microarrays for miRNA
expression profiling. Several design strategies have been
proposed in recent years for PCR-based miRNA detection
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(for review, see Kong et al. 2009). Most of these assays were
originally designed to analyze the expression of one or a few
miRNAs at a time. However, there are some important
primer design considerations when multiple miRNAs are
analyzed simultaneously in a single profiling experiment.
For example, the primers should have homogenous properties so that all the assays can be performed with similar
efficiency under the same experimental condition. More
importantly, the primers should be highly specific for the
targeted miRNAs with little cross-reactivity to other unintended targets. Unfortunately, most existing primer design
programs select primers based on a single template of
limited genetic complexity (Chen et al. 2002), leading to
frequent nonspecific PCR amplifications. In addition, some
important design criteria, such as those for the prevention
of primer dimer formation, have not been adequately
considered. Thus, an investigator often has to identify
primers for genes of interest by trial and error.
To address these potential issues, we have developed a
new bioinformatics algorithm for miRNA primer design by
incorporating multiple design filters to improve miRNA
assay specificity, sensitivity, and homogeneity. This algorithm has incorporated multiple design features that have
been proven to be important for PCR performance in our
previous studies (Wang and Seed 2003a). In addition, the
new design algorithm also includes novel primer features
that are uniquely associated with miRNA assays. These new
miRNA assays rely on fluorescent detection of amplified
PCR products by sequence nonselective dye, SYBR Green I.
We have experimentally validated 96 miRNA assays designed with this new algorithm for cancer-related miRNA
expression profiling, and the validation results indicate
that these new assays have robust performance for the
measurement of miRNA expression profiles in a variety
of biological samples.
RESULTS
Overall experimental strategy
One unique challenge in miRNA assay development is the
design of specific reverse transcription (RT) and PCR
primers for these very small molecules (z22 nt). A typical
mRNA molecule is more than 1-kb long, and it is relatively
easy to select gene-specific sequence regions for primer
design. In contrast, the design space is very limited for
miRNA primers since the miRNA length is the same as that
of a typical PCR primer.
The overall experimental strategy using these miRNA
assays is summarized in Figure 1. As the first step of the
experiment, multiplexed RT reaction is performed using a
pool of RT primers. These RT primers anneal specifically to
the target miRNAs, leading to a pool of mixed cDNA
products from the miRNAs of interest. By performing a
multiplexed RT reaction, the overall experimental cost is

significantly reduced since only one RT reaction is needed
for each RNA sample. After the RT reaction, separate realtime PCR assays are performed to quantify the expression
of individual miRNAs. Each PCR is performed with two
primers that are uniquely associated with the miRNA of
interest, one with a miRNA-specific sequence and the other
from the unique tag sequence in the RT primer. Thus, these
primers are not likely to cross-react to primers from other
miRNA assays even though multiplexed RT reactions are
performed. Many bioinformatics parameters have been
included in the design algorithm to avoid primer crossreactivity and potential primer dimer and secondary structure formation, as well as to ensure uniform PCR assay
properties, such as primer Tm, length, GC content, and
the amplicon length. In this way, all miRNA assays can be
performed together under the same experimental condition. The overall workflow for the new bioinformatics
primer design algorithm is summarized in Figure 2 and
described in details below.
Partition of the miRNA sequence
One critical component of the design algorithm is the
proper partition of the mature miRNA sequence. The 39end sequence of the miRNA is used for the design of the RT
primer, and the 59-end sequence is used for the design of
the PCR reverse primer. Because mature miRNAs are very
short, it is usually not possible to identify long nonoverlapping miRNA-specific bases for primer annealing in
both RT and PCR. To partly address this issue, the RT
reaction is performed at a low temperature (25°C) so that
only a short stretch of miRNA-specific nucleotides are
needed for annealing. The number of miRNA-specific bases
in an RT primer is mainly determined by two factors, the
melting temperature (Tm) requirement and the potential
of forming primer dimer. All RT primers contain 7–10
miRNA-specific bases.
It has been well known that primers with the same length
may have very different Tm values. The most accurate way
to date to determine the Tm is the nearest neighbor method
(Sugimoto et al. 1995; SantaLucia 1998), which is used in
our design program to calculate primer Tm values. The Tm
is calculated with the following formula:
Tm ¼ DH8

 8

DS  R lnðCT =4Þ ;

where R is the gas constant (1.987 cal/K mol), CT is the
primer concentration, DH° is the enthalpy change, and DS°
is the entropy change. DH° and DS° are calculated with the
published thermodynamic parameters (Sugimoto et al.
1995; SantaLucia 1998). The design program initially selects
seven miRNA-specific bases for the RT primer. If the
calculated Tm for these miRNA-specific bases is lower than
20°C, then more miRNA-specific bases will be added to the
RT primer until the Tm requirement is met. In this way, all
www.rnajournal.org
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primer to increase its Tm. In the end,
the primer length is in the range of 18–
24. Multiple design criteria are used for
the addition of these extra nucleotides.
The Tm range for all reverse primers is
61°C–63°C. The Tm value is calculated
using the nearest neighbor method as
described above. To avoid potential
primer cross-reactivity due to low
sequence complexity, a stretch of four
or more continuous same nucleotides is
not allowed. The newly added extra
nucleotides could potentially crosshybridize to miRNA-specific bases in
the reverse and RT primers, leading to a
primer dimer. Therefore, these added
FIGURE 1. The experimental strategy for a new miRNA expression profiling platform with nucleotides are screened against the
real-time RT-PCR. Multiplexed RT is performed with a pool of miRNA-specific RT primers. miRNA sequence for potential dimer
These RT primers contain unique tag sequences at the 59-end. Real-time PCR is then formation. The design algorithm also
performed with the cDNA templates generated from the multiplexed RT reaction. The PCR
considers primer secondary structure,
reverse primer specifically anneals to the 39-end of the cDNA template, and the PCR forward
because a high degree of secondary
primer specifically anneals to the tag sequence in the RT primer.
structure can retard primer annealing,
leading to reduced PCR efficiency. In
addition, secondary structures may also contribute to
miRNAs can be efficiently annealed and reverse transcribed
nonspecific PCR amplification. Multiple secondary strucunder the same RT condition.
ture filters are used in the algorithm for primer screening as
Besides the Tm requirement, another important considwe described previously (Wang and Seed 2003a). A
eration is the avoidance of potential primer dimer formacandidate sequence tag is rejected if any one of these design
tion. This is especially a serious issue for the sequencecriteria is not met.
independent fluorescence detection method, such as SYBR
Green real-time PCR. After the RT reaction, most RT
primers are still left intact in the reaction mixture. Thus,
Design of the PCR forward primer and the RT primer
the RT primers could potentially cross-hybridize to PCR
The experimental strategy requires a unique sequence tag in
primers, leading to a hetero-primer dimer. It is also posthe RT primer sequence. This sequence tag is used as
sible that an RT or PCR primer could self-anneal, leading
template for PCR forward primer annealing. Thus, the
to a homo-primer dimer. The primer 39-end residues are
successful design of the forward primer also determines the
especially important for controlling primer dimer formatag sequence and completes the design of the RT primer.
tion because DNA polymerase extension can be greatly
Random 22-mer sequences are generated and evaluated for
reduced by mismatches (Kwok et al. 1990; Huang et al.
their qualification as the forward primer using multiple
1992). In our design program, the last four bases of an RT
design criteria. In this way, each miRNA assay has a
primer should not anneal perfectly to itself or to the PCR
forward primer that is uniquely associated with the assay.
primers. If this requirement is not met, then a new
This sequence length is long enough to permit generation
partition of the miRNA sequence would be evaluated.
of assay-specific primers, while reducing the potential for
After the successful partition of the miRNA sequence, the
cross-hybridization and allowing cost-effective generation
39-ends of both the RT and PCR reverse primers have been
of large primer sets.
determined. The full RT and reverse primer sequences are
As the forward primer does not contain any miRNAthen designed by adding extra sequence tags as described in
specific bases, more stringent screening criteria can be
details below.
applied to evaluate a large number of random sequences
in the primer selection process. A primer candidate would
Design of the PCR reverse primer
be discarded if any one of the criteria is not met. The Tm
range for the forward primer is 61°C–63°C, the same as
After the partition of the miRNA sequence, only part of the
that for the reverse primer as determined by the nearest
miRNA bases can be used for reverse primer design. In
neighbor method. Similarly, other design filters described
general, this is not enough for specific primer annealing
earlier for the reverse primer are also applied to the design
under standard PCR conditions. To address this issue, extra
of the forward primer. To further enhance primer sequence
random nucleotides are added to the 59-end of the reverse
718
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the reverse primer. A candidate sequence is rejected if it
could potentially cross-react to other primers in the assay.
Because of these stringent requirements, thousands of
candidate sequences were rejected during the design process before a qualified sequence was found as the forward
primer. Finally, the RT primer is designed by attaching the
complementary sequence of the forward primer to the
miRNA-specific nucleotides as determined by the miRNA
sequence partition process.
Experimental evaluation of the miRNA assays

FIGURE 2. A flowchart for the primer design program for the realtime RT-PCR assays.

complexity, the DUST program is used and any sequence
identified by DUST is rejected (Hancock and Armstrong
1994). In addition, the GC content is in the range of 45%–
55% to ensure uniform priming. The 39-end nucleotides
contribute most to nonspecific primer extension, especially
if the binding of these residues is relatively stable (Rychlik
1995). Thus, the design program evaluates the DG value for
the last five residues at the 39-end and a threshold value of
9 kcal/mol is used for sequence rejection.
Total RNA is typically used in real-time RT-PCR for
miRNA quantification. As total RNA contains thousands
of distinct transcripts, the likelihood of primer crosshybridization to unintended templates is greatly increased.
To address this issue, multiple specificity filters are included in the design algorithm. One main filter is the
rejection of sequences with a 15-mer perfect match to any
unintended human genes in the genome. The identification
of redundant 15-mers is performed using a bioinformatics
algorithm that we developed previously (Wang and Seed
2003b). To further reduce cross-reactivity, BLAST search is
performed against all known human genes, and a threshold
BLAST score of 30 is used for primer rejection (threshold
value recommended from previous studies) (Wang and
Seed 2003b). As the last step of PCR forward primer design,
primer candidates are evaluated against the RT primer and

A small-scale validation experiment was first performed to
evaluate the specificity of these miRNA assays using two
synthetic miRNAs (miR-124a and let-7a) and five miRNA
assays. As shown in Figure 3A, miR-124a was only detected
by the miR-124a real-time PCR assay, but not by any other
assay included in the study; let-7a was sensitively detected
by the let-7a assay. let-7c and let-7b miRNAs are different
from let-7a by one and two nucleotides, respectively.
Despite the small sequence variations, let-7a RNA was
not detected by the assay designed for let-7b and there was
only 3% cross-reactivity to let-7a miRNA using the let-7c
assay. Therefore, these miRNA assays have a higher
specificity than existing miRNA microarray platforms,
which cannot detect a single nucleotide variation.
Next, we identified a set of 96 cancer-related miRNAs by
bioinformatics data analysis of public microarray data as
well as literature survey. The expression changes of these
miRNAs have been shown to be associated with various
cancers in previous studies. Real-time RT-PCR assays were
designed using the new design algorithm for these cancerrelated miRNAs, and the primer sequences are summarized
in Supplemental Table 1. At present, the normalization of
miRNA expression profiling data is challenging, and there
is no consensus on the best normalization strategy. Commonly used methods for miRNA raw data processing
include median or mean normalization, which uses median
or mean value of the raw readings as the normalization
factor to correct for intersample signal variation. However,
many miRNAs may not be expressed in a biological sample,
and thus median or mean value may be skewed toward the
assay readings for lowly expressed miRNAs, which tend to
be more variable compared with the readings for more
abundantly expressed miRNAs. In our analysis, a new
normalization strategy was adopted. Instead of using the
plate median or mean for normalization, the readings from
eight miRNAs with relatively high expression were averaged
and the mean value was used as the plate normalization
factor (see Materials and Methods for details). This
normalization strategy was used in all subsequent analyses
of the expression profiles of 96 cancer-specific miRNAs.
The assay specificity was further evaluated with two cell
lines using 96 cancer-related miRNA assays. One cell line is
ovarian cancer SKOV-3, and the other is SKOV-3-miR-146a,
www.rnajournal.org
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FIGURE 3. Real-time RT-PCR validation of the miRNA assays. (A)
The assay specificity was evaluated with two synthetic miRNAs, miR124a and let-7a. Five miRNA assays were evaluated for the detection
of these synthetic miRNAs. The assay readings of miR-124a by
miRNA-124a assay, and let-7a by let-7a assay were used as the relative
standards (100%) for the analysis of assay cross-reactivity. (B) The
assay specificity was evaluated with two cell lines and 96 cancerrelated miRNA assays. One cell line is SKOV-3 and the other one is
SKOV-3-miR-146a, which is SKOV-3 with stably expressed miR-146a.
Each data point represents the normalized readings from one miRNA
assay in both cell lines.

which is SKOV-3 with a stably expressed miR-146a using a
lentiviral expression system. As shown in Figure 3B, miR146a was overexpressed in SKOV-3-miR146a cells by over
2000 times compared with SKOV-3 cells. Interestingly, the
detection of other miRNAs was little affected by miR-146a
overexpression. The miRNA expression profiles between
the two cell lines were highly correlated after excluding
miR-146a from the calculation (Pearson r = 0.99). Most
noticeably, although miR-146b differs from miR-146a by a
single nucleotide, its expression detection was not affected
by the high abundance of miR-146a (Fig. 3B, crossreactivity <0.2%). In a similar way, we also compared
SKOV-3 cells with SKOV-3-miR-200a cells (SKOV-3 with
720
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overexpressed miR-200a). As in the case of miR-146a,
overexpression of miR-200a did not affect the quantification of other miRNAs, including two highly homologous
miRNAs from the same miR-200 family, miR-200c and
miR-141 (data not shown).
The assay specificity was also evaluated with frozen
tumor tissue samples. As shown in Figure 4B, there was
little nonspecific amplification from negative control RT
reactions (using Escherichia coli total RNA as the RT
template) from all 96 miRNA assays. In contrast, most
miRNAs of interest were specifically amplified in cervical
tumor tissues with high PCR efficiency (Fig. 4A). Melting
curve analysis (plotted as the first derivatives of absorbance
in relation to temperature) was also performed to evaluate
the specificity of the PCR products. Multiple peaks in a
melting curve usually represent mixed PCR products
including nonspecific amplicons. As shown in Figure 4C,
all the melting curves for the amplified products contain
single peaks, indicating specific PCR amplification. The
PCR product size was further checked by agarose gel
electrophoresis, and the expected amplicon sizes were
observed from all the PCR assays (data not shown).
Having successfully validated the miRNA assays with cell
lines and frozen tumor tissues, we then evaluated whether
these assays can be robustly applied to profile miRNA
expression in formalin-fixed paraffin-embedded (FFPE)
tissues. RNA extracted from FFPE tissues is usually highly
degraded and challenging to apply to microarrays. We first
determined the miRNA expression profiles from two
consecutive sections from the same tumor block. Similar
to the result shown in the cell line comparison analysis, the
miRNA expression profiles of the two tissue sections were
highly correlated (r = 0.99). Thus, the profiling result was
highly reproducible for FFPE tissue analysis. To further
explore the usefulness of these new miRNA assays, we
profiled four FFPE breast tumors, including two high-grade
and two low-grade tumors. The two miRNA expression
profiles from each group (high grade or low grade) were
averaged, and differentially expressed miRNAs between the
two groups are presented in Figure 5. Several miRNAs were
overexpressed in high-grade tumors, and some of these
miRNAs are already known to promote tumorigenesis. For
example, the miR-17-92 cluster has been shown by many
studies to promote tumor growth (He et al. 2005).
Interestingly, three miRNAs from this cluster were found
to be overexpressed in high-grade breast tumors in our
analysis (miR-17, miR-18, and miR-20). Another interesting overexpressed miRNA is miR-21, which is already
known to be overexpressed in almost all human cancers.
The most overexpressed miRNA in our analysis, miR-210
has recently been shown to be an independent prognostic
marker in breast cancer (Camps et al. 2008). On the other
hand, miRNAs underexpressed in high-grade tumors
included several known tumor suppressors. For example,
let-7 miRNAs are known to suppress the progression of
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assays could be used as a reliable tool to systematically
study miRNA expression in FFPE samples.
DISCUSSION

FIGURE 4. Real-time RT-PCR validation of 96 cancer-related
miRNA assays. (A) Real-time RT-PCR was performed with the total
RNA extracted from a frozen cervical tumor tissue. Each line in the
plot represents the amplification curve for one miRNA. (B) Real-time
RT-PCR was performed with the total RNA from E. coli. (C) Melting
curve analysis of the real-time PCR profile for the cervical tissue
miRNAs. For illustration purpose, only 10 dissociation curves are
displayed here for 10 of the 96 miRNA assays. Other dissociation
curves (data not shown) were similar to those presented here.

many human cancers (Roush and Slack 2008); tumor
suppressor miR-34 miRNAs are required for p53-mediated
cell death (He et al. 2007). Thus, our preliminary analysis
of four FFPE tumor tissues suggests that the new miRNA

Microarrays are by far the most widely used technique for
transcriptional expression profiling studies. Microarrays are
routinely used to simultaneously measure the expression of
tens of thousands of mRNA transcripts in a single experiment, and thus the experimental cost per measurement is
greatly reduced. Microarrays have also been successfully
applied to miRNA expression profiling analysis, and
multiple microarray platforms have been proposed in
recent years for miRNA studies. To date, most published
miRNA profiling studies were performed with microarrays.
Despite their popularity, there are also major issues
associated with miRNA microarrays. One concern is the
throughput of miRNA microarrays. There are only several
hundred known miRNAs in humans. Therefore, there is
little cost-saving benefit when microarrays are applied to
miRNA studies. On the other hand, microarrays are a
solution hybridization-based detection technology, and the
signals are generally considered to be more noisy and
less specific than that from real-time PCR. Thus in general
real-time PCR experiments have to be performed to subsequently validate the findings from microarrays. Given
the relatively low-throughput nature of miRNA profiling
analysis, real-time RT-PCR would in theory be ideal when
both experimental cost and assay reliability are considered.
Unfortunately, real-time RT-PCR has not been widely
adopted to date for miRNA profiling analysis. One major
roadblock is the availability of cheap and reliable miRNA
assays. Our study is an attempt to overcome this obstacle.
Currently, one popular PCR-based method for miRNA
quantification is based on TaqMan chemistry (Chen et al.
2005). In a TaqMan qPCR assay, two PCR primers and
one TaqMan probe are required. In contrast, our PCR
assays are based on sequence-independent fluorescence
detection using SYBR Green. This is to significantly reduce
the experimental cost because SYBR Green real-time PCR
is by far the cheapest and most widely used PCR quantification method. A miRNA assay design strategy has
recently been proposed based on SYBR Green real-time
PCR (Sharbati-Tehrani et al. 2008). The qPCR assay
requires one miRNA-specific primer and two universal
primers for the analysis of one or a few miRNAs in one
experiment (Sharbati-Tehrani et al. 2008). In contrast,
our assay primers are designed using a robust bioinformatics algorithm so that multiplexed RT-PCR can be
performed for miRNA expression profiling. Many design
features have been implemented in both the experimental
assay strategy and the primer design algorithm for assay
specificity, sensitivity, and homogeneity. The assay design
has been extensively validated experimentally for 96 cancerrelated miRNA assays, and the results indicate that
www.rnajournal.org
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included 1 mL of 103 RT buffer, 0.4 mL of
253 dNTP (100mM), 0.4 mL of RT primer
mixture (250 nM), 0.5 mL of reverse transcriptase, 0.5 mL of RNase inhibitor, 2.2 mL
of H2O, and 5 mL of RNA template (20–100
ng). The RT reaction mixture was incubated
for 20 min at 25°C and for 60 min at 37°C
and was finally heat-inactivated for 5 min at
85°C. Real-time PCR was performed with
power SYBR Green PCR master mix (Applied
Biosystems). The real-time PCR running
protocol was 10 min at 95°C, followed by
three cycles of amplification (15 sec at 95°C,
1 min at 55°C, and 30 sec at 60°C). Then 32
additional amplification cycles were performed (10 sec at 95°C and 30 sec at 60°C).
FIGURE 5. miRNA expression profiling of FFPE breast tumor tissues. The expression ratio is In this way, miRNA expression in each tumor
defined as the miRNA expression fold change between the high-grade and low-grade tumors.
sample was profiled using a single 96-well
miRNAs with the most extreme expression ratios (>2 or <0.5) are presented here.
PCR plate.
In order to directly compare the expression profiles of different RNA samples, raw expression values
these new miRNA assays can be reliably applied to a variety
from the real-time PCR experiments were normalized using a new
of RNA samples including challenging clinical samples
analysis strategy. First, the expression values of 96 miRNAs
with minute amounts of highly degraded RNA. With these
from an RNA sample were sorted so that the first miRNA had
new assays, the experimental cost for the profiling of 96
the highest expression reading and the last miRNA had the
cancer-related miRNAs is only less than one-tenth comlowest reading. Next, a plate normalization factor n was calculated
pared with that of microarrays. Also importantly, the high
by averaging eight selected miRNA expression values as the
measurement accuracy of these miRNA assays will save
following:

researchers valuable time and resources down the road for
the validation of the profiling results. To promote the idea
of using real-time RT-PCR for miRNA expression profiling, we have made freely available all the primer
sequences of our validated miRNA assays. It is likely that
in the near future more and more miRNA profiling
analyses will be performed using real-time RT-PCR instead
of microarrays.

n¼

1 9
+ E5i ;
8 i¼2

where E represents the miRNA expression reading and the
subscript 5i represents the order of eight selected miRNAs in
the sorted list (i.e., 10th, 15th . . . 45th miRNAs on the list).
Finally, normalized expression values in each PCR plate were
calculated by dividing raw expression values with the plate
normalization factor n.

MATERIALS AND METHODS
RNA samples

SUPPLEMENTAL MATERIAL

A variety of RNA samples were analyzed to evaluate the performance of the new miRNA assays. Synthesized miRNA oligonucleotides were purchased from Integrated DNA Technologies
(IDT). For the cell line comparison analysis, SKOV-3 cancer cells
were stably transfected with miR-146a or miR-200a constructs
using a lentiviral expression system according to the manufacturer’s protocol (System Biosciences). Total RNA samples from
cells or frozen tissues were prepared with a mirVana miRNA
isolation kit (Ambion). FFPE tissue section slides were used to
extract total RNA from four breast tumors (two grade I and two
grade III tumors) using the miRNeasy FFPE Kit for miRNA
isolation (Qiagen).

Supplemental material can be found at http://www.rnajournal.org.
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